Ōra Medical Clinic: Your Partner in Wellness & Weight Management
Virtually serving California and the state of Washington, Ōra Medical Clinic offers personalized medical weight loss programs, including treatments with Semaglutide and Tirzepatide, to help you achieve your health and wellness goals.
Why Choose Ōra Medical Clinic?
At Ōra Medical Clinic, we believe that true wellness is achieved under expert medical guidance. We are dedicated to helping patients live healthier lives through personalized services like medical weight loss, all carefully supervised by our qualified physicians.

Advanced Weight Loss Options
Our advanced weight loss medications, supervised by physicians, target hormones like GLP-1 and GIP to enhance appetite control and metabolic health. These treatments are tailored to your needs, ensuring safe and effective weight management.
Physician-supervised GLP-1 & GIP treatments for real results
Customized plans to curb cravings and boost metabolism
Safe, effective, and tailored to your unique body chemistry
Discover Your Path to Wellness
Schedule your consultation today and discover how our physician-supervised programs can help you achieve your health and wellness goals.
Significant Outcomes: By the Numbers
Data from major studies highlights the success rates and additional health benefits associated with these advanced medical weight loss options.
Significant Weight Loss
Clinical trials show GLP-1 therapies help patients achieve an average weight loss exceeding 15% of their body weight.
Enhanced Results
Dual-action GIP/GLP-1 therapies have demonstrated even greater average weight loss, often exceeding 20%, in clinical studies.
Major Milestones Achieved
In some studies, a significant portion of patients utilizing specific doses achieved weight loss greater than 25%.
Reduced Cardiovascular Risk
In a major clinical trial (SELECT), Semaglutide reduced the risk of major adverse cardiovascular events (like heart attack or stroke) by 20% in eligible patients with overweight/obesity and existing heart disease.
Applying Medical Breakthroughs in Everyday Clinical Practice
Breakthrough weight loss medications with remarkable ability to may protect the body from within and support healing
WeGovy® / Ozempic®
Active Ingredient: Semaglutide
Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and weight loss. It works by mimicking the natural GLP-1 hormone, helping to regulate blood sugar and reduce appetite.
Semaglutide binds to receptors in the body, specifically in the pancreas, stomach, and brain. This leads to increased insulin sensitivity, slowed gastric emptying, appetite suppression, and enhanced satiety.
Along with diet and exercise, patients had up to 15% of weight loss which was maintain over 2 years.
Nausea, vomiting, constipation, bloating and gas, gastritis, fatigue
Individuals with personal or family history Medullary Thyroid Cancer or MEN2 Syndrome. Those who are pregnant, breast feeding, of trying to conceive.
Mounjaro® / Zepbound®
Active Ingredient: Tirzepatide
Tirzepatide is a GLP-1 and GIP receptor agonist used for type 2 diabetes and weight loss. It works by mimicking the natural GLP-1 and GIP hormones, enhancing body’s metabolic process which result in weight loss and better type 2 diabetes control.
Tirzepatide binds to receptors in the body, helping to better control blood sugar levels and appetite by slowing gastric emptying and acting on hunger centers in the brain to reduce cravings and promote satiety. Additionally, GIP may enhance the body’s ability to break down and utilize stored fat for energy.
Along with diet and exercise, patients experienced up to a 22% weight loss with Tirzepatide. A recent study involving 18,000 participants showed that Tirzepatide (42%) was more effective than Semaglutide (18%) in achieving ≥15% weight loss.
Nausea, vomiting, constipation, diarrhea, bloating and gas, gastritis, fatigue
Individuals with personal or family history Medullary Thyroid Cancer or MEN2 Syndrome. Those who are pregnant, breast feeding, of trying to conceive.
Metformin
Metformin is a medication that helps your body manage blood sugar and improve metabolism. It is commonly used for type 2 diabetes, insulin resistance, and as part of a weight management plan.
Metformin helps your body use insulin more efficiently, reducing fat storage and supporting stable energy levels. When combined with GLP-1 medications, Metformin can enhance the overall effect on appetite control, blood sugar regulation, and fat metabolism — helping you reach your weight loss goals more effectively.
Metformin shows modest weight loss of typically 2% to 5% of body weight that is gradual over months and can be long term with lifestyle changes especially in those with PCOS, Insulin Resistance, Prediabetes, and Diabetes.
Patients often notice steadier energy, fewer sugar cravings, and better blood sugar control within days to weeks. When paired with a GLP-1, it can support greater fat loss while helping maintain lean muscle and metabolic health.Affecting >10% - Nausea (most common, especially at the start), vomiting, diarrhea, constipation, abdominal pain or bloating. These usually occur early on and often improve as the body adjusts.
Affecting 1-10% - Fatigue, dizziness (especially with low food or fluid intake), indigestion or reflux, headaches, injection site reaction (mild redness, swelling, or itching).
Mild stomach upset, diarrhea, nausea, or gas, usually improving as your body adjusts.
You have severe kidney or liver disease, are pregnant or breastfeeding, or have a history of lactic acidosis. Always consult your healthcare provider before starting.
NAD+ (Injection)
NAD+ is a natural molecule found in every cell of your body that helps create energy, repair cells, and keep you healthy. As we age or experience stress, our NAD+ levels drop — which can leave us feeling tired, foggy, or slower to recover.
NAD+ injections deliver this important molecule directly into your system for better absorption than pills. This helps your cells produce energy more efficiently, boosts metabolism, supports healthy aging, and improves overall vitality.
Most people notice more energy, clearer thinking, better mood, and faster recovery. Supporting NAD+ levels may also make it easier to burn fat and stay active while improving long-term wellness.
Mild redness or warmth at the injection site, brief headache, or lightheadedness.
Those who are pregnant, breastfeeding, or have active cancer should avoid using NAD+.
Sermorelin
Sermorelin is a peptide that helps your body naturally produce more growth hormone — a key hormone for energy, muscle tone, sleep, and recovery. Growth hormone levels naturally decrease with age, which can make it harder to stay fit, focused, and energized.
Sermorelin works by gently stimulating your pituitary gland to release your own growth hormone, rather than replacing it. This helps improve metabolism, increase lean muscle, reduce body fat, support better sleep, and promote healthy aging.
With regular use and a healthy lifestyle, many people notice more energy, better sleep, improved mood, faster recovery, and easier weight management over time.
Mild redness or irritation at the injection site, temporary headache, or feeling tired after the first few doses.
Those who are pregnant, breastfeeding, or have active cancer should avoid using Sermorelin.
B12
Vitamin B12 is an essential vitamin that helps your body make energy, red blood cells, and healthy nerves. Low levels of B12 can cause fatigue, brain fog, mood changes, and slow metabolism.
B12 injections deliver the vitamin directly into your muscle for quick and effective absorption. This helps your body convert food into energy more efficiently, supports metabolism, boosts mood, and enhances mental clarity.
Many people report feeling more energetic, focused, and alert within days to weeks. Regular B12 injections can also support metabolism, mood balance, and overall wellness — especially if you follow a vegetarian or low-meat diet.
Mild redness or tenderness at the injection site, slight headache, or brief lightheadedness.
Individuals with allergies to cobalt or vitamin B12, or those with certain medical conditions (such as Leber’s disease)
Integrating cutting-edge weight loss medications into everyday clinical practice can significantly enhance patient outcomes. These treatments not only aid in weight management but also offer protective benefits for overall health.
Expanding Therapeutic benefits of GLP-1/GIP
Semaglutide and Tirzepatide offer benefits beyond weight loss
Heart Health
Tirzepatide has shown to significantly reduced the risk of cardiovascular death or worsening heart failure events, along with improvements in health related quality of life, functional capacity, and exercise tolerance.
Read StudyLiver Health
Semaglutide helps improve liver health in people with metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease, by reducing inflammation and liver damage.
Read StudyKidney Health
The study showed Semaglutide helped slow the progression of chronic kidney disease (CKD) in diabetic patients. It improves blood sugar control and reduces risk factors like high blood pressure and inflammation, contributing to kidney protection.
Read StudyBrain Health
Semaglutide is associated with a reduced risk of developing Alzheimer's disease in patients with diabetes and may have protective effects against Alzheimer's in people with type 2 diabetes.
Read StudySleep Health
In two large clinical trials, participants who received Tirzepatide experienced a significant reduction in the number of breathing interruptions during sleep, known as the apnea-hypopnea index (AHI), compared to those who received a placebo. Additionally, those on Tirzepatide lost more weight, had lower blood pressure, and reported better sleep quality, suggesting Tirzepatide can be a promising treatment option for individuals struggling with both obesity and sleep apnea.
Read StudyEndocrine Health
Three years of treatment with Tirzepatide in individuals with obesity and prediabetes resulted in substantial and sustained weight reduction and a significantly lower risk of progression to type 2 diabetes compared to those treated with placebo.
Read Study
Introducing Dr. Pardis Poorzand: A Leader in Metabolic Health
Dr. Pardis Poorzand is a board certified Internal Medicine physician with nearly ten years of experience specializing in the understanding, prevention, and treatment of complex chronic diseases, many of which are related to metabolic syndrome (including obesity, high blood pressure, high cholesterol, and diabetes). She takes a holistic approach to care, emphasizing the importance of addressing obesity as a root cause of metabolic issues rather than merely managing its symptoms. Dr. Poorzand is particularly passionate about integrating innovative treatments such as GLP-1 medications with personalized nutrition, physical activity, and lifestyle changes to help patients achieve sustainable, long-term health improvements.
Board Certified in Internal Medicine with nearly a decade of clinical experience.
Specializes in managing obesity and metabolic syndrome by focusing on root causes rather than just downstream consequences.
Utilizes modern treatments, including GLP-1 medications, to support weight management and inspire comprehensive lifestyle improvements.
FAQs
GLP-1 (Glucagon-Like Peptide-1) mimics the action of a naturally occurring peptide called glucagon-like peptide 1. This hormone is produced in the gut in response to food and stimulates the production of both glucagon and insulin to regulate blood sugar levels.
GLP-1s are not recommended for patients with a family history of edullary hyroid arcinoma (MTC) or Multiple Endocrine Neoplasia yndrome type 2 (MEN 2). They are also contraindicated in patients who are pregnant or breastfeeding.
The most common side effects include nausea, vomiting, diarrhea, and constipation. Patients may experience fatigue or dizziness, particularly if they are not staying well hydrated or are following a severely calorie restricted diet. There is also a risk of low blood sugar, especially in diabetic patients who are taking other blood glucose lowering medications.
Sarcopenia, the loss of muscle mass, can occur with any form of severe calorie restricted diet not just those involving GLP-1 medications. Patients on GLP-1 therapy, especially postmenopausal women, are at increased risk of sarcopenia if their weight loss is not supported by regular exercise and adequate protein intake. This is why it's crucial to have a qualified medical provider monitor your weight loss and guide you through the process.
Contact Ōra Medial Clinic
Fill up the form and our Team will get back to you within 24 hours.



